TRPV4: New therapeutic target for inflammatory bowel diseases

Biochemical Pharmacology

Volumn 89, Issue 2, 2014, Pages 157-161

  Vergnolle, Nathalie ^a,b,c  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

IBD; Mucosal Inflammation; TRPV4; Visceral Pain

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CYTOCHROME P450; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEINASE ACTIVATED RECEPTOR 2; RANTES; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 4; VANILLOID RECEPTOR 4 AGONIST; VANILLOID RECEPTOR AGONIST;

ALLODYNIA; EDEMA; ENTERITIS; GLIA CELL; HUMAN; HYPERALGESIA; HYPEREMIA; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY CELL; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; MUCUS; NONHUMAN; PAIN RECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; VISCERAL PAIN;

IBD; MUCOSAL INFLAMMATION; TRPV4; VISCERAL PAIN;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; PAIN; SULFONAMIDES; TRPV CATION CHANNELS;

EID: 84899461856     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2014.01.005     Document Type: Note

References (44)

1. R. Strotmann, C. Harteneck, K. Nunnenmacher, G. Schultz, and T.D. Plant OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity Nat Cell Biol 2 2000 695 702
2. T.D. Plant, R. Strotmann, TRPV4. A Multifunctional Nonselective Cation Channel with Complex Regulation, 2007.
3. J. Dai, T.J. Cho, S. Unger, E. Lausch, G. Nishimura, and O.H. Kim et al. TRPV4-pathy, a novel channelopathy affecting diverse systems J Hum Gen 55 2010 400 402
4. B. Nilius, and T. Voets The puzzle of TRPV4 channelopathies EMBO Rep 14 2013 152 163
5. P. Verma, A. Kumar, and C. Goswami TRPV4-mediated channelopathies Channels (Austin) 4 2010 319 328
6. F. Vincent, and M.A. Duncton TRPV4 agonists and antagonists Curr Top Med Chem 11 2011 2216 2226
7. A. Denadai-Souza, L. Martin, M.A. de Paula, M.C. de Avellar, M.N. Muscara, and N. Vergnolle et al. Role of transient receptor potential vanilloid 4 in rat joint inflammation Arthritis Rheum 64 2012 1848 1858
8. Y. Chen, S.H. Williams, A.L. McNulty, J.H. Hong, S.H. Lee, and N.E. Rothfusz et al. Temporomandibular joint pain: a critical role for TRPV4 in the trigeminal ganglion Pain 154 2013 1295 1304
9. N. Vergnolle, N. Cenac, C. Altier, L. Cellars, K. Chapman, and G.W. Zamponi et al. A role for transient receptor potential vanilloid 4 in tonicity-induced neurogenic inflammation Br J Pharmacol 159 2010 1161 1173
10. E. Ceppa, F. Cattaruzza, V. Lyo, S. Amadesi, J.C. Pelayo, and D.P. Poole et al. Transient receptor potential ion channels V4 and A1 contribute to pancreatitis pain in mice Am J Physiol Gastrointest Liver Physiol 299 2010 G556 G571
11. L. Ye, S. Kleiner, J. Wu, R. Sah, R.K. Gupta, and A.S. Banks et al. TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis Cell 151 2012 96 110
12. L. Merrill, B.M. Girard, V. May, and M.A. Vizzard Transcriptional and translational plasticity in rodent urinary bladder TRP channels with urinary bladder inflammation, bladder dysfunction, or postnatal maturation J Mol Neurosci 48 2012 744 756
13. E. D'Aldebert, N. Cenac, P. Rousset, L. Martin, C. Rolland, and K. Chapman et al. Transient receptor potential vanilloid 4 activated inflammatory signals by intestinal epithelial cells and colitis in mice Gastroenterology 140 2011 275 285
14. J. Fichna, A. Mokrowiecka, A.I. Cygankiewicz, P.K. Zakrzewski, E. Malecka-Panas, and A. Janecka et al. Transient receptor potential vanilloid 4 blockade protects against experimental colitis in mice: a new strategy for inflammatory bowel diseases treatment? Neurogastroenterol Motil 24 2012 e557 e560
15. L. Zhang, S. Jones, K. Brody, M. Costa, and S.J. Brookes Thermosensitive transient receptor potential channels in vagal afferent neurons of the mouse Am J Physiol Gastrointest Liver Physiol 286 2004 G983 G991
16. W.E. Sipe, S.M. Brierley, C.M. Martin, B.D. Phillis, F.B. Cruz, and E.F. Grady et al. Transient receptor potential vanilloid 4 mediates protease activated receptor 2-induced sensitization of colonic afferent nerves and visceral hyperalgesia Am J Physiol Gastrointest Liver Physiol 294 2008 G1288 G1298
17. S.M. Brierley, A.J. Page, P.A. Hughes, B. Adam, T. Liebregts, and N.J. Cooper et al. Selective role for TRPV4 ion channels in visceral sensory pathways Gastroenterology 134 2008 2059 2069
18. N. Cenac, C. Altier, K. Chapman, W. Liedtke, G. Zamponi, and N. Vergnolle Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms Gastroenterology 135 2008 937 946 946 e931-932
19. P. Holzer Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system Pharmacol Ther 131 2011 142 170
20. N. Cenac, C. Altier, J.P. Motta, E. d'Aldebert, S. Galeano, and G.W. Zamponi et al. Potentiation of TRPV4 signalling by histamine and serotonin: an important mechanism for visceral hypersensitivity Gut 59 2010 481 488
21. L. De Petrocellis, P. Orlando, A.S. Moriello, G. Aviello, C. Stott, and A.A. Izzo et al. Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation Acta Physiol (Oxf) 204 2012 255 266
22. N. Cenac, A.M. Coelho, C. Nguyen, S. Compton, P. Andrade-Gordon, and W.K. MacNaughton et al. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2 Am J Pathol 161 2002 1903 1915
23. E. Hyun, P. Andrade-Gordon, M. Steinhoff, P.L. Beck, and N. Vergnolle Contribution of bone marrow-derived cells to the pro-inflammatory effects of protease-activated receptor-2 in colitis Inflamm Res 59 2010 699 709
24. E. Hyun, P. Andrade-Gordon, M. Steinhoff, and N. Vergnolle Protease-activated receptor-2 activation: a major actor in intestinal inflammation Gut 57 2008 1222 1229
25. W. Knecht, G.S. Cottrell, S. Amadesi, J. Mohlin, A. Skaregarde, and K. Gedda et al. Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia J Biol Chem 282 2007 26089 26100
26. N. Vergnolle Proteinase-activated receptors (PARs) in infection and inflammation in the gut Int J Biochem Cell Biol 40 2008 1219 1227
27. N. Vergnolle, N.W. Bunnett, K.A. Sharkey, V. Brussee, S.J. Compton, and E.F. Grady et al. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway Nat Med 7 2001 821 826
28. A.D. Grant, G.S. Cottrell, S. Amadesi, M. Trevisani, P. Nicoletti, and S. Materazzi et al. Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice J Physiol 578 2007 715 733
29. H. Peng, U. Lewandrowski, B. Muller, A. Sickmann, G. Walz, and T. Wegierski Identification of a protein kinase C-dependent phosphorylation site involved in sensitization of TRPV4 channel Biochem Biophys Res Commun 391 2010 1721 1725
30. D.P. Poole, S. Amadesi, N.A. Veldhuis, F.C. Abogadie, T. Lieu, and W. Darby et al. Protease-activated receptor 2 (PAR2) protein and transient receptor potential vanilloid 4 (TRPV4) protein coupling is required for sustained inflammatory signaling J Biol Chem 288 2013 5790 5802
31. J. Vriens, G. Owsianik, B. Fisslthaler, M. Suzuki, A. Janssens, and T. Voets et al. Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium Circ Res 97 2005 908 915
32. E. D'Aldebert, J.L. Wallace, and N. Vergnolle Regulation of transcient receptor potential vanilloid 4 activity by protease-activated receptors and hydrogen sulfide Inflamm Res 60 2011 1
33. N. Cenac, L. Cellars, M. Steinhoff, P. Andrade-Gordon, M.D. Hollenberg, and J.L. Wallace et al. Proteinase-activated receptor-1 is an anti-inflammatory signal for colitis mediated by a type 2 immune response Inflamm Bowel Dis 11 2005 792 798
34. N. Vergnolle Clinical relevance of proteinase-activated receptors in the gut Gut 54 2005 867 874
35. N. Vergnolle Protease-activated receptors as drug targets in inflammation and pain Pharmacol Ther 123 2009 292 309
36. M.D. Hollenberg, M. Saifeddine, S. Sandhu, S. Houle, and N. Vergnolle Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo Br J Pharmacol 143 2004 443 454
37. C. Auge, D. Balz-Hara, M. Steinhoff, N. Vergnolle, and N. Cenac Protease-activated receptor-4 (PAR 4): a role as inhibitor of visceral pain and hypersensitivity Neurogastroenterol Motil 21 2009 1189-e1107
38. G.R. Martin, G.W. McKnight, M.S. Dicay, C.S. Coffin, J.G. Ferraz, and J.L. Wallace Hydrogen sulphide synthesis in the rat and mouse gastrointestinal tract Dig Liver Dis 42 2010 103 109
39. J.L. Wallace Hydrogen sulfide-releasing anti-inflammatory drugs Trends Pharmacol Sci 28 2007 501 505
40. J.L. Wallace Physiological and pathophysiological roles of hydrogen sulfide in the gastrointestinal tract Antioxid Redox Signal 12 2010 1125 1133
41. M. Shikano, T. Ueda, T. Kamiya, Y. Ishida, T. Yamada, and T. Mizushima et al. Acid inhibits TRPV4-mediated Ca(2)(+) influx in mouse esophageal epithelial cells Neurogastroenterol Motil 23 2011 1020 1028 e1497
42. T. Ueda, M. Shikano, T. Kamiya, T. Joh, and S. Ugawa The TRPV4 channel is a novel regulator of intracellular Ca2+ in human esophageal epithelial cells Am J Physiol Gastrointest Liver Physiol 301 2011 G138 G147
43. F. Vincent, A. Acevedo, M.T. Nguyen, M. Dourado, J. DeFalco, and A. Gustafson et al. Identification and characterization of novel TRPV4 modulators Biochem Biophys Res Commun 389 2009 490 494
44. W. Liedtke, D.M. Tobin, C.I. Bargmann, and J.M. Friedman Mammalian TRPV4 (VR-OAC) directs behavioral responses to osmotic and mechanical stimuli in Caenorhabditis elegans Proc Natl Acad Sci U S A 100 Suppl. 2 2003 14531 14536